← Back to Patent Explorer
EP0173552A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Recombinant DNA compounds and the expression of polypeptides such as tPA

Assignee: Case Western Reserve University
•
Filing: 1985-08-23
•
Granted: —
•
Expires: 2005-08-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A circular recombinant DNA compound of formula I wherein the repeated alphabetic sequences (the number of repetitions of which is arbitrarily depicted in said formulal therein represent the following: the «B» region comprises nucleotides whose sequence contains a bGH polyadenylation signal; the «F» region comprises the nucleotides whose ordered codons represent a gene for the synthesis of a pre-selected polypeptide other than bGH, including genomic and other intron containing forms thereof; the «P» region comprises a nucleotide whose sequence contains a promoter capable of initiating transcription of said gene, and the «M» region comprises optional nucleotides whose sequence contains a selectable marker which, upon incorporation of said DNA compound into the expressed genetic material of a living cell, can be utilized to select a cell in which incorporation has taken place; and the acircular forms thereof are disclosed together with cells and cell lines incorporating these DNA compounds in the expressed genetic material. The cells and cell lines are then capable of producing the pre-selected polypeptides, such as tissue plasminogen activator (tPA) in high yield.

Inventors

  • 👤 Edward C. Goodwin
  • 👤 Daniel P. Palermo
  • 👤 Leonard Edwin Post
  • 👤 Fritz Max Rottman
  • 👤 Darrell R. Thomsen
  • 👤 Richard P. Woychik

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-24 05:27
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6456; C12N9/6459; C12N15/00; C12N15/09; C12N15/63; C12N15/70; C12N15/79; C12N15/85; C12Y; C12Y304/00; C12Y304/21; C12Y304/21069; A; A61; A61B; A61B17/00; A61B2017/00004

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 136 words
A circular recombinant DNA compound of formula I wherein the repeated alphabetic sequences (the number of repetitions of which is arbitrarily depicted in said formula) therein represent the following: the "B" region comprises nucleotides whose sequence contains a bGH polyadenylation signal; the "F" region comprises the nucleotides whose ordered codons contain a gene for the synthesis of a pre-selected polypeptide other than bGH, including genomic and other intron containing forms thereof; the "P" region comprises a nucleotide whose sequence contains a promoter capable of initiating transcription of said gene, and the "M" region comprises optional nucleotides whose sequence contains a selectable marker which, upon incorporation of said DNA compound into the expressed genetic material of a living cell, can be utilized to select a cell in which incorporation has taken place; and the acircular forms thereof.
Claim 2
Dependent Claim 136 words
A circular recombinant DNA compound of formula I wherein the repeated alphabetic sequences (the number of repetitions of which is arbitrarily depicted in said formula) therein represent the following: the "B" region comprises nucleotides whose sequence contains a bGH polyadenylation signal; the "F" region comprises the nucleotides whose ordered codons contain a gene for the synthesis of a pre-selected polypeptide other than bGH, including genomic and other intron containing forms thereof; the "P" region comprises a nucleotide whose sequence contains a promoter capable of initiating transcription of said gene, and the "M" region comprises optional nucleotides whose sequence contains a selectable marker which, upon incorporation of said DNA compound into the expressed genetic material of a living cell, can be utilized to select a cell in which incorporation has taken place; and the acircular forms thereof.
Claim 3
Dependent Claim 15 words
A compound according to claim 1 where the "P" region comprises the CMV I.E. promoter.
Claim 4
Dependent Claim 37 words
A compound according to claim 2 wherein the "B" region comprises the bGH gDNA nucleotide sequence from the PstI (Blunt-ended) cleavage site in the codons upstream from the fourth intron downstream to the nearest EcoRI cleavage site.
Claim 5
Dependent Claim 36 words
A compound according to claim 2 wherein the "B" region comprises the bGH gDNA nucleotide sequence from the PvuII cleavage site in the codons downstream from the fourth intron downstream to the nearest EcoRI cleavage site.
Claim 6
Dependent Claim 17 words
A compound according to claim 2 wherein the "B" region comprises the following bGH gDNA nucleotide sequence:
Claim 7
Dependent Claim 15 words
A compound according to claim 5, wherein the "F" region comprises the tPA cDNA gene.
Claim 8
Dependent Claim 22 words
A compound according to claim 1, which has one or more of the characteristics defined in any of claims 2 to 6.
Claim 9
Dependent Claim 20 words
A higher eukaryote cell or cell line whose expressed genetic material comprises a DNA compound according to any preceding claim.
Claim 10
Dependent Claim 15 words
A cell or cell line according to claim 8, wherein the DNA compound expresses tPA.
Claim 11
Dependent Claim 25 words
A method for the expression of a polypeptide, e.g. tPA, which comprises culturing a cell or cell line according to claim 8 or claim 9.

References Cited (Backward Citations)

EP0093619A1 Cited
EP0112012A2 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag